Literature DB >> 9255111

The outcome of ankylosing spondylitis: a study of 100 patients.

J T Gran1, J F Skomsvoll.   

Abstract

The outcome was studied in 100 patients with adult-onset primary ankylosing spondylitis (AS). After a mean disease duration of 16 yr, 51.5% of the patients were employed in full-time work. Cessation of work occurred at a mean disease duration of 15.6 yr, and was significantly associated with female sex, low levels of education, acute anterior uveitis, 'bamboo spine' and the co-existence of non-rheumatic diseases. Functional outcome was studied by analysing activities of daily living, and revealed similar findings in males and females. Most of the loss of function occurred during the first 10 yr of disease, and correlated significantly with the occurrence of peripheral arthritis, spinal X-ray changes of AS and development of 'bamboo spine'. After > 20 yr of disease, > 80% of the patients still complained of daily pain and stiffness, and > 60% reported daily use of drugs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9255111     DOI: 10.1093/rheumatology/36.7.766

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  72 in total

1.  Anti-TNFalpha: a new dimension in the pharmacotherapy of the spondyloarthropathies !?

Authors:  J Braun; J Sieper
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

Review 2.  Treatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha: first clinical and laboratory experiences.

Authors:  J Braun; J Xiang; J Brandt; H Maetzel; H Haibel; P Wu; S Kohler; M Rudwaleit; S Siegert; A Radbruch; A Thiel; J Sieper
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

3.  How to diagnose axial spondyloarthropathy early.

Authors:  N Barkham; H Marzo-Ortega; D McGonagle; P Emery
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

Review 4.  [Ankylosing spondylitis--current state of imaging including scoring methods].

Authors:  C E Althoff; K G Hermann; J Braun; J Sieper
Journal:  Z Rheumatol       Date:  2006-12       Impact factor: 1.372

Review 5.  Mechanisms of pathologic new bone formation.

Authors:  Kurt de Vlam; Rik J U Lories; Frank P Luyten
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

6.  Ventricular Tacyhcardia in A Patient with A Previous History of Endocarditis and Ankylosan Spondylitis: A Challenging Case.

Authors:  Yavuzer Koza; Muhammed Hakan Taş; Ziya Şimşek; Fuat Gündoğdu
Journal:  Eurasian J Med       Date:  2016-10

7.  Ankylosing spondylitis: patterns of radiographic involvement--a re-examination of accepted principles in a cohort of 769 patients.

Authors:  Jennifer H Jang; Michael M Ward; Adam N Rucker; John D Reveille; John C Davis; Michael H Weisman; Thomas J Learch
Journal:  Radiology       Date:  2010-10-22       Impact factor: 11.105

Review 8.  Current guidelines for the drug treatment of ankylosing spondylitis.

Authors:  E Toussirot; D Wendling
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

9.  Withdrawal from labour force due to work disability in patients with ankylosing spondylitis.

Authors:  A Boonen; A Chorus; H Miedema; D van der Heijde; R Landewé; H Schouten; H van der Tempel; S van der Linden
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 10.  Golimumab for the treatment of ankylosing spondylitis: a NICE single technology appraisal.

Authors:  Nigel Armstrong; Manuela Joore; Thea van Asselt; Kate Misso; Nathan Manning; Florian Tomini; Jos Kleijnen; Rob Riemsma
Journal:  Pharmacoeconomics       Date:  2013-05       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.